There is a new treatment for a disease which strikes children called Juvenile Rheumatoid Arthritis.
This condition can be very debilitating and very difficult to treat.
Now doctors reporting at the annual meeting of the American College of Rheumatology describe a study of a new treatment which shows imporvement in 75% of the children involved.
The treatment consists of two injections per week of a new type of drug called embrel.
This drug works by blocking the action of a factor in the patient's blood which leads to the destruction of the patient's joints.
This is good news for patients with juvenile rheumatoid arthritis.
I'm Medical Editor, Dr. Ted Castele, with the Medical Moment.
Return to Medical Moments Page
Return to Dr. Ted's Home Page
Go to the School of Medicine's Home Page